Neurology Neuroimmunology & Neuroinflammation, 2026 Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis Chitnis T., Singhal T., Zurawski J. et al. Olink Target 48NeurologyPathophysiologySerum | | | | |
Frontiers in Immunology, 2026 Circulating fibroblasts and neutrophils co-expressing CDH11+ and chemokine receptors in rheumatoid and psoriatic arthritis: a shared mechanism of ‘arthritis spreading’? Kyriakidi M., Vetsika E., Fragoulis G. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Nature Medicine, 2026 Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial Donovan J., Duc Bang N., Dong H. et al. Olink Explore 3072/384NeurologyInfectious DiseasesPatient StratificationCSF | | | | |
Journal of Pediatric Gastroenterology and Nutrition, 2026 Beyond eosinophils: A proteomic dissection of remodeling and inflammation in suspected eosinophilic esophagitis Eindor‐Abarbanel A., Moss‐ Ophir N., Agajany N. et al. Olink Explore 3072/384GastroenterologyPathophysiologySerum | | | | |
Blood Neoplasia, 2026 Proteome-wide Mendelian Randomisation Identifies Protein Associations and Therapeutic Targets for B-cell Malignancy Went M., Mills C., Sud A. et al. Olink Explore 3072/384OncologyPathophysiologyPlasma | | | | |
Annals of the Rheumatic Diseases, 2026 Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach Cross H., Peng J., McDonnell T. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
Cytotherapy, 2026 Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL Lauener M., Normand M., Ngo T. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyCell Culture Supernatant | | | | |
Metabolism, 2026 Multi-omics profiling reveals CKM syndrome severity as a gradient risk factor for cancer: A prospective cohort study Huang Y., Zhang Y., Zhang Y. et al. Olink Explore 3072/384Metabolic DiseasesCVDNephrologyPathophysiologyPlasma | | | | |
mBio, 2026 Lineage-matched Oropouche virus mRNA-LNP vaccines confer complete, cross-protective immunity in mice Yamada Y., Cha I., Kang S. et al. Olink Target 48 MouseInfectious DiseasesPathophysiologyMouse Cell Culture Supernatant | | | | |
FEBS Open Bio, 2026 Microglial dynamics and ferroptosis induction in human
iPSC
‐derived neuron–astrocyte–microglia tri‐cultures Li H., Ohmiya H., Sakamoto S. et al. Olink Target 48NeurologyTechnical EvaluationCell Culture Supernatant | | | | |
Lifestyle Genomics, 2026 Inflammatory proteins mediate the causal association between sleep traits and breast cancer: a Mendelian randomization study Zhou J., Mao L. Olink Target 96OncologyNeurologyPathophysiologyPlasma | | | | |
Carcinogenesis, 2026 Plasma proteomic profiling identified prognostic indicators with therapeutic potential for colorectal cancer Xie X., Zhou J., Wu Q. et al. Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma | | | | |
Cell Metabolism, 2026 Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night Marjot T., Smith K., Westcott F. et al. Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma | | | | |
HemaSphere, 2026 Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy Vänttinen I., Saad J., Ruokoranta T. et al. Olink Target 48OncologyPatient StratificationBone Marrow Plasma | | | | |
Aging Cell, 2026 The Secretome of Human Trophoblast Stem Cells Attenuates Senescence‐Associated Traits Abdelmohsen K., Martindale J., Rossi M. et al. Olink Target 96AgingPathophysiologyCell Culture SupernatantEV Lysate | | | | |
Advanced Biology, 2026 Proteomic Signatures Over Age Reveal Significant Changes From Infancy Till Late Adulthood Delemarre E., Smits H., van Baarle D. et al. Olink Target 96AgingEpidemiologyEpidemiologyPlasma | | | | |
Environment International, 2026 Molecular basis for the early life sensitization of the brain to ultrafine carbonaceous particles: a study of the brain proteome, telomeres, and epigenetic modelling Vanbrabant K., Rasking L., Alfano R. et al. Olink Target 96 MouseNeurologyEnvironmental Health & ToxicologyPathophysiologyMouse Tissue Lysate | | | | |
Nature Medicine, 2026 BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial Fedak R., Ruggerie R., Shan Y. et al. Olink Target 96Immunological & Inflammatory DiseasesImmunotherapyPathophysiologySerum | | | | |
European Journal of Heart Failure, 2026 Proteomic patterns according to ejection fraction: an EMPEROR-Program analysis Ferreira J., Fioretti F., Sumin M. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
Toxicology and Applied Pharmacology, 2026 Sinapic acid attenuates colistin-driven nephrotoxicity by targeting the miRNA-21/SIRT1/NF-κB pathway and facilitating tubular repair and inflammation in a rat model Öz M., Şimşek H., Özdemir S. et al. Olink Target 48 MouseInfectious DiseasesPathophysiologyRat Serum | | | | |